Orchestra BioMed Holdings Cash Flow Statement (2022-2025) | OBIO

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M
Depreciation and Depletion 0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M
Share-based Compensation 0.07M0.22M2.22M0.86M1.49M1.71M3.51M0.92M2.59M2.76M2.36M2.90M2.96M3.25M3.01M
Gains from Sales and Divestitures 0.06M0.07M0.08M0.01M0.02M0.14M0.42M0.18M0.63M0.92M
Gains from Investment Securities 0.14M1.01M-0.04M0.23M0.32M-0.01M0.68M0.54M0.39M0.43M0.27M
Non-cash Items 7.40M6.60M2.43M8.19M9.00M2.95M10.70M9.30M3.65M8.30M4.21M
Cash from Operations -5.32M-7.96M-7.26M-8.74M-14.38M-10.49M-10.28M-10.97M-13.11M-10.21M-13.70M-13.54M-16.62M-15.53M-14.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.13M0.14M0.15M0.18M1.06M1.06M1.06M0.64M0.59M0.33M0.36M0.23M0.15M0.15M0.19M
Amortization of Deferred Charges 0.06M0.04M0.04M0.04M0.04M0.04M0.04M0.00M0.05M0.05M0.06M
Depreciation & Amortization (CF) 0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.08M
Change in Working Capital
Change in Receivables -0.04M0.00M0.02M-0.02M0.10M-0.09M0.01M-0.03M0.01M0.04M-0.04M-0.00M-0.01M-0.03M
Change in Inventory -0.04M0.10M0.20M-0.05M-0.04M-0.05M-0.04M0.01M-0.03M-0.04M0.16M-0.06M-0.04M0.05M0.18M
Change in Account Payables 0.10M0.07M0.11M0.10M
Change in Accured Expenses 0.20M0.47M1.62M1.06M-1.79M0.78M0.67M0.49M-1.28M3.73M1.23M-0.71M-0.20M1.09M3.41M
Investing Activities
Capital Expenditures 0.05M0.27M0.22M0.05M0.04M0.03M0.02M-0.00M0.11M0.01M0.07M0.11M0.11M0.03M0.31M
Change in Acquisitions & Divestments 51.49M37.11M29.61M29.18M10.61M17.23M16.01M16.39M9.51M
Cash from Investing Activities -0.05M-0.47M-0.22M-63.38M-43.53M8.12M12.95M33.15M5.86M10.42M0.56M-3.75M13.00M16.36M-38.58M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments 1.00M5.45M
Change in Capital Stock
Shares Issued 0.07M0.04M0.00M0.01M0.06M0.00M0.15M0.02M0.17M14.85M0.09M
Preferred Shares Issued 27.28M82.60M27.28M
Misc.
Cash from Financing Activities 24.76M86.08M-2.50M-5.09M56.82M0.09M0.00M-10.70M0.02M0.17M15.04M13.95M-0.30M-0.43M76.40M
Change in Cash 19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M
Beginning Cash Balance -17.97M-76.34M10.71M159.78M127.67M116.84M100.72M73.15M64.94M53.54M52.66M60.14M44.10M23.92M50.69M
Free Cash Flow -5.37M-8.23M-7.48M-8.80M-14.42M-10.52M-10.30M-10.97M-13.22M-10.21M-13.77M-13.64M-16.73M-15.56M-14.86M
Net Cash Flow 19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M